ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Telesis Bio Inc (PK)

Telesis Bio Inc (PK) (TBIO)

0,30
-0,10
(-25,00%)
Fermé 06 Janvier 10:00PM

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
0,30
Prix Achat
0,25
Prix Vente
0,45
Volume échangé
2 907
0,25 Fourchette du Jour 0,45
0,25 Plage de 52 semaines 3,95
Cap du marché
Clôture Veille
0,40
Ouverture
0,272
Dernière Transaction
1
@
0.318
Dernière heure de transaction
Volume financier
US$ 890
VWAP
0,306318
Volume moyen (3 m)
8 078
Actions en circulation
1 775 839
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,79
Bénéfice par action (BPA)
-3,3
Chiffre d'affairess
15,2M
Bénéfice net
-5,85M

À propos de Telesis Bio Inc (PK)

Secteur
Lab Analytical Instruments
Industrie
Lab Analytical Instruments
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
-
Telesis Bio Inc (PK) est coté dans le secteur Lab Analytical Instruments de la OTCMarkets avec le ticker TBIO. Le dernier cours de clôture d'Telesis Bio (PK) était de US$0,40. Au cours de la dernière année, les actions de Telesis Bio (PK) ont été négociées dans une fourchette de prix de US$ 0,25 à US$ 3,95.

Telesis Bio (PK) compte actuellement 1 775 839 actions en circulation. La capitalisation boursière d'Telesis Bio (PK) est de US$710 335,60 . Telesis Bio (PK) a un ratio cours/bénéfice (ratio PE) de -1.79.

TBIO Dernières nouvelles

Transgenomic Announces Executive Changes

Paul Kinnon Named President, Chief Executive Officer and Director

Transgenomic to Present at the Craig-Hallum 4th Annual Alpha Select Conference

Transgenomic, Inc. (OTCBB: TBIO) today announced that Craig Tuttle, Chief Executive Officer of Transgenomic, will be presenting at the Craig-Hallum Capital Group’s 2013 Alpha Select...

Quest Diagnostics Introduces Comprehensive Opioid Therapy Genetic Test Based on CYP450 Biomarker License with Transgenomic

Quest Diagnostics Introduces Comprehensive Opioid Therapy Genetic Test Based on CYP450 Biomarker License with Transgenomic Believed to be first clinical test to identify variants of four enzymes...

Transgenomic Reports Second Quarter 2013 Financial Results

Conference Call to Be Held at 5:00 PM Eastern Time Today

Reminder: Transgenomic to Hold Second Quarter Financial Results Conference Call on August 6, 2013

Transgenomic, Inc. (OTC/BB: TBIO) today announced the following Webcast:   What: Transgenomic, Inc. Second Quarter 2013 Financial Results and...

Transgenomic to Hold Second Quarter Financial Results Conference Call on August 6, 2013

Transgenomic, Inc. (OTCBB: TBIO) today announced the following Webcast:       What: Transgenomic, Inc. Second Quarter 2013 Financial...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.11-26.82926829270.410.450.25129460.37811092CS
4-0.21-41.17647058820.510.690.2580530.49570257CS
12-2.35-88.6792452832.652.850.2580781.15913389CS
260.05200.253.950.25236982.80981458CS
520.05200.253.950.25226962.80981458CS
1560.05200.253.950.25212032.80981458CS
2600.05200.253.950.25196522.80981458CS

TBIO - Frequently Asked Questions (FAQ)

What is the current Telesis Bio (PK) share price?
The current share price of Telesis Bio (PK) is US$ 0,30
How many Telesis Bio (PK) shares are in issue?
Telesis Bio (PK) has 1 775 839 shares in issue
What is the market cap of Telesis Bio (PK)?
The market capitalisation of Telesis Bio (PK) is USD 710,34k
What is the 1 year trading range for Telesis Bio (PK) share price?
Telesis Bio (PK) has traded in the range of US$ 0,25 to US$ 3,95 during the past year
What is the PE ratio of Telesis Bio (PK)?
The price to earnings ratio of Telesis Bio (PK) is -1,79
What is the cash to sales ratio of Telesis Bio (PK)?
The cash to sales ratio of Telesis Bio (PK) is 0,69
What is the reporting currency for Telesis Bio (PK)?
Telesis Bio (PK) reports financial results in USD
What is the latest annual turnover for Telesis Bio (PK)?
The latest annual turnover of Telesis Bio (PK) is USD 15,2M
What is the latest annual profit for Telesis Bio (PK)?
The latest annual profit of Telesis Bio (PK) is USD -5,85M
What is the registered address of Telesis Bio (PK)?
The registered address for Telesis Bio (PK) is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Telesis Bio (PK) website address?
The website address for Telesis Bio (PK) is www.omniab.com
Which industry sector does Telesis Bio (PK) operate in?
Telesis Bio (PK) operates in the LAB ANALYTICAL INSTRUMENTS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
ICNBIconic Brands Inc (CE)
US$ 0,001
(99 900,00%)
100,03k
INREInland Real Estate Income Trust Inc (PK)
US$ 10,696
(97 136,36%)
1,14k
NTACNew Technology Acquisition Holdings (CE)
US$ 0,0002
(19 900,00%)
3,04k
NEOMNeoMedia Technologies Inc (CE)
US$ 0,0002
(19 900,00%)
17,97k
CRMBQCrumbs Bake Shop Inc (CE)
US$ 0,012
(11 900,00%)
500
AAGRAfrican Agriculture Holdings Inc (CE)
US$ 0,000001
(-99,99%)
4,9k
ONCIOn4 Communications Inc (PK)
US$ 0,000001
(-99,50%)
450k
TMNATingo Inc (CE)
US$ 0,000001
(-99,00%)
5k
FUVVArcimoto Inc (CE)
US$ 0,000001
(-99,00%)
597
NWTTNW Tech Capital Inc (PK)
US$ 0,000001
(-99,00%)
111,11k
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0,0046
(21,05%)
877,98M
HMBLHUMBL Inc (PK)
US$ 0,0009
(0,00%)
395,38M
RDARRaadr Inc (PK)
US$ 0,0013
(4,00%)
197,64M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0,0002
(100,00%)
179,47M
HCMCHealthier Choices Management Corporation (PK)
US$ 0,000001
(0,00%)
139,17M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock